Biological characterization of 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) as a selective sphingosine kinase-2 inhibitor and anticancer agent

Liu, K; Guo, TL; Hait, NC; Allegood, J; Parikh, HI; Xu, W; Kellogg, GE; Grant, S; Spiegel, S; Zhang, S

HERO ID

4851209

Reference Type

Journal Article

Year

2013

Language

English

PMID

23437140

HERO ID 4851209
In Press No
Year 2013
Title Biological characterization of 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) as a selective sphingosine kinase-2 inhibitor and anticancer agent
Authors Liu, K; Guo, TL; Hait, NC; Allegood, J; Parikh, HI; Xu, W; Kellogg, GE; Grant, S; Spiegel, S; Zhang, S
Journal PLoS ONE
Volume 8
Issue 2
Page Numbers e56471
Abstract In our effort to develop selective sphingosine kinase-2 (SphK2) inhibitors as pharmacological tools, a thiazolidine-2,4-dione analogue, 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145), was synthesized and biologically characterized. Biochemical assay results indicate that K145 is a selective SphK2 inhibitor. Molecular modeling studies also support this notion. In vitro studies using human leukemia U937 cells demonstrated that K145 accumulates in U937 cells, suppresses the S1P level, and inhibits SphK2. K145 also exhibited inhibitory effects on the growth of U937 cells as well as apoptotic effects in U937 cells, and that these effects may be through the inhibition of down-stream ERK and Akt signaling pathways. K145 also significantly inhibited the growth of U937 tumors in nude mice by both intraperitoneal and oral administration, thus demonstrating its in vivo efficacy as a potential lead anticancer agent. The antitumor activity of K145 was also confirmed in a syngeneic mouse model by implanting murine breast cancer JC cells in BALB/c mice. Collectively, these results strongly encourage further optimization of K145 as a novel lead compound for development of more potent and selective SphK2 inhibitors.
Doi 10.1371/journal.pone.0056471
Pmid 23437140
Wosid WOS:000315184200080
Is Certified Translation No
Dupe Override No
Is Public Yes
Language Text English